Latest news, press releases, and SEC filings for Alnylam Pharmaceuticals Inc (ALNY) https://caymanjournal.com/stock/ALNY en-us Copyright 2026, Cayman Journal editorial@caymanjournal.com (Editorial Team) webmaster@caymanjournal.com (Web Master) Mon, 27 Apr 2026 23:47:33 GMT 60 https://caymanjournal.com/logo.png https://caymanjournal.com 144 144 # 🧾 What This Document Is This is Alnylam's **Annual Report to Shareholders (ARS)**. Think of it as the company's yearly "report card" sent directly to its owners. It's meant to provide a comprehensive, yet digestible, overview of everything that happened in the past year—financial performance, str https://caymanjournal.com/stock/ALNY/sec-filing/0001140361-26-013365 https://caymanjournal.com/stock/ALNY/sec-filing/0001140361-26-013365 Mon, 06 Apr 2026 00:00:00 GMT SEC Filing # 🧾 What This Document Is This is Alnylam's **DEF 14A, or Definitive Proxy Statement**. It's a formal document sent to shareholders ahead of the company's annual meeting. Its purpose is to provide all the information needed for shareholders to vote on important company matters. Think of it as an ag https://caymanjournal.com/stock/ALNY/sec-filing/0001628280-26-023923 https://caymanjournal.com/stock/ALNY/sec-filing/0001628280-26-023923 Mon, 06 Apr 2026 00:00:00 GMT SEC Filing